CMV virus can infect the foetus and cause hearing loss
While Caroline Star, 37, from in Whitechapel, East London, was still expecting, she had caught a little-known but common virus, cytomegalovirus (CMV). (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2014 Category: Consumer Health News Source Type: news

Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds
CMV dangerous for low birth weight infants, but mom can be tested before delivery to see if she carries virus Source: HealthDay Related MedlinePlus Pages: Breastfeeding, Cytomegalovirus Infections, Premature Babies (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 23, 2014 Category: Consumer Health News Source Type: news

Maternal breast milk is risk factor for cytomegalovirus transmission in premature infants
Premature infants, especially those born with very low-birth-weight, are particularly vulnerable to cytomegalovirus infection because of their immature immune systems. Maternal breast milk is a primary source of postnatal cytomegalovirus in very-low-birth-weight patients, researchers say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 22, 2014 Category: Science Source Type: news

Maternal breast milk is risk factor for cytomegalovirus transmission in premature infants
(Emory Health Sciences) Premature infants, especially those born with very low-birth-weight, are particularly vulnerable to cytomegalovirus infection because of their immature immune systems. Maternal breast milk is a primary source of postnatal cytomegalovirus in very-low-birth-weight patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 22, 2014 Category: Infectious Diseases Source Type: news

Cytomegalovirus linked to maternal breast milk in very-low-birth-weight infants
(The JAMA Network Journals) The primary source of postnatal infection with cytomagelovirus, a common virus usually without symptoms in very-low-birth-weight infants appeared to be maternal breast milk because no infections were linked to transfusions of cytomagelovirus-seronegative and leukoreduced blood products. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 22, 2014 Category: Infectious Diseases Source Type: news

What is Gianotti-Crosti Syndrome?
Discussion Infectious exanthams are usually considered when rashes are bilateral, symmetric and relatively widespread. They usually involve the trunk too and have associated systemic symptoms. Gianotti-Crosti syndrome (GCS) or acropapular dermatitis of childhood is often misdiagnosed because it doesn’t follow these rules. A discussion of common viral exanthams can be reviewed here and a differential diagnosis of rashes by pattern and distributions can be reviewed here. Dr. Ferdinando Gianotti came from a poor family, underwent several personal tragedies, but entered medicine and created the first department of pedia...
Source: PediatricEducation.org - September 8, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Growth of newborn babies' brains tracked
Conclusion This study has mapped out the growth rate of the major structures of the brain in 87 apparently healthy neonates from within a week of birth up to 90 days. A study of this nature can help our understanding of the growth and development of the brain and our ability to monitor brain development over time. The fact the investigation had no apparent side effects is also welcome. However, as the authors point out, the relatively small size of the study means the results cannot be used as a reference for normal development. Larger and more ethnically diverse studies would be required. The goal of establishing data ...
Source: NHS News Feed - August 12, 2014 Category: Consumer Health News Tags: Pregnancy/child Source Type: news

July's top stories: Merck CMV Phase III trial, Sanofi vaccine study results
Merck enrolled the first patient in its global Phase III clinical trial of letermovir for the prevention of cytomegalovirus infection in high-risk bone marrow transplant patients, while Sanofi Pasteur reported positive results from its Phase III deng… (Source: Drug Development Technology)
Source: Drug Development Technology - August 4, 2014 Category: Pharmaceuticals Source Type: news

Merck begins Phase III letermovir trial for prevention of CMV infection
US-based pharmaceutical firm Merck has enrolled the first patient in a global Phase III clinical trial of letermovir (MK-8228), an investigational antiviral agent, for prevention of cytomegalovirus (CMV) infection in high-risk bone marrow transplant … (Source: Drug Development Technology)
Source: Drug Development Technology - July 24, 2014 Category: Pharmaceuticals Source Type: news

Merck Initiates Phase 3 Study of Letermovir, an Investigational Antiviral for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:J...
Source: Merck.com - Research and Development News - July 24, 2014 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News Source Type: news

Consumer Information on: artus CMV RGQ MDx Kit - P130027
The artus CMV RGQ MDx Kit is a laboratory test used to measure the amount of Cytomegalovirus (CMV) DNA in a patient?s plasma. Viral DNA is the genetic material from CMV. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - June 30, 2014 Category: Medical Equipment Source Type: news

Designer T Cells Fight Viruses After Transplants
WASHINGTON (AP) — Bone marrow transplants save thousands of lives but patients are vulnerable to severe viral infections in the months afterward, until their new immune system kicks in. Now scientists are developing protection for that risky period — injections of cells specially designed to fend off up to five different viruses at once. MoreNo Streams for You? What Supreme Court's Aereo Ruling Means NBC NewsJessica N. Turner: Moms, Put on That Swimsuit Huffington PostKnow a Debbie Downer? Stop Trying to Cheer Her Up NBC NewsViva! Pope Francis Flaunts Argentina Soccer Jersey NBC NewsUruguay eliminates Italy; Did Suarez...
Source: TIME: Top Science and Health Stories - June 25, 2014 Category: Science Authors: hannahgoldberg2014 Tags: Uncategorized medicine Research Science Source Type: news

Telemedicine Diagnosis of CMV Retinitis by NonexpertsTelemedicine Diagnosis of CMV Retinitis by Nonexperts
Nonophthalmologists with limited special training can't consistently diagnose cytomegalovirus (CMV) retinitis by telemedicine, researchers say. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 25, 2014 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

ELISA-Based Assay for IP-1 Detection from Filter Paper Samples
IP-10 is a small pro-inflammatory chemokine secreted primarily from monocytes and fibroblasts. Alterations in IP-10 levels have been associated with inflammatory conditions including viral and bacterial infections, immune dysfunction, and tumor development. IP-10 is increasingly recognized as a biomarker that predicts severity of various diseases and can be used in the immunodiagnostics of Mycobacterium tuberculosis and cytomegalovirus infection. Here, we describe an ELISA-based method to detect IP-10 from dried blood and plasma spot samples. (Source: Springer protocols feed by Immunology)
Source: Springer protocols feed by Immunology - June 10, 2014 Category: Allergy & Immunology Source Type: news

Doubt over tests for hearing loss from congenital cytomegalovirus
Hearing loss at birth associated with congenital cytomegalovirus (cCMV) infection cannot be reliably predicted by the amount of virus in saliva or blood spots, US research suggests. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - May 9, 2014 Category: Nursing Source Type: news